October 13, 2023 Comments Off on New patent for Glaxosmithkline drug JESDUVROQ Posted in: Patent Added Annual Drug Patent Expirations for JESDUVROQ Jesduvroq is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are six patents protecting…
The post New patent for Glaxosmithkline drug JESDUVROQ appeare…
October 13, 2023 Comments Off on New patent for Intra-cellular drug CAPLYTA Posted in: Patent Added Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. It is available from two suppliers. There are fifteen patents protecting…
The post New patent for Intra-cellular drug CAPLYTA appeared f…